111 related articles for article (PubMed ID: 6998248)
1. Soluble immune complexes in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Glikmann G; Svehag SE; Hansen E; Hansen O; Husby S; Nielsen H; Farrell C
Acta Neurol Scand; 1980 Jun; 61(6):333-43. PubMed ID: 6998248
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
Dorta-Contreras A; Silva-Somoza R
Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.
Salmi A; Ziola B; Reunanen M; Julkunen I; Wager O
Acta Neurol Scand; 1982 Jul; 66(1):1-15. PubMed ID: 7113673
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid immune complexes in multiple sclerosis.
Deicher H; Meyer zu Schwabedissen H; Baruth B; Patzold U; Haller P
Experientia; 1979 Sep; 35(9):1249-50. PubMed ID: 488296
[TBL] [Abstract][Full Text] [Related]
5. Detection and isolation of immune complexes in multiple sclerosis cerebrospinal fluid.
Coyle PK
J Neuroimmunol; 1987 May; 15(1):97-107. PubMed ID: 3571487
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
Rawes JA; Calabrese VP; Khan OA; DeVries GH
Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course.
Procaccia S; Lanzanova D; Caputo D; Ferrante P; Papini E; Gasparini A; Colucci A; Bianchi M; Villa P; Blasio R
Acta Neurol Scand; 1988 May; 77(5):373-81. PubMed ID: 3046225
[TBL] [Abstract][Full Text] [Related]
8. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases.
Page N; Perruisseau G; Steck AJ
J Neurol Sci; 1983 Jul; 60(1):23-30. PubMed ID: 6192219
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis. Cerebrospinal fluid immune complexes that bind C1q.
Rudick RA; Bidlack JM; Knutson DW
Arch Neurol; 1985 Sep; 42(9):856-8. PubMed ID: 3875333
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid proteins in neurological diseases. Studies on agar gel electrophoresis protein profiles.
Jensen K
Acta Neurol Scand Suppl; 1978; 70():1-268. PubMed ID: 81584
[No Abstract] [Full Text] [Related]
11. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
Matà S; Lolli F; Söderström M; Pinto F; Link H
Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
[TBL] [Abstract][Full Text] [Related]
13. T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.
Holmøy T; Vandvik B; Vartdal F
Mult Scler; 2003 Jun; 9(3):228-34. PubMed ID: 12814167
[TBL] [Abstract][Full Text] [Related]
14. Determination of IgG subgroups in cerebrospinal fluid of multiple sclerosis patients and others.
Eickhoff K; Kaschka W; Skvaril F; Theilkaes L; Heipertz R
Acta Neurol Scand; 1979; 60(5):277-82. PubMed ID: 120670
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients.
Kostulas VK; Link H; Lefvert AK
Arch Neurol; 1987 Oct; 44(10):1041-4. PubMed ID: 3632376
[TBL] [Abstract][Full Text] [Related]
16. T-lymphocyte subpopulation levels and immunoglobulin changes in the cerebrospinal fluid of patients with neurologic disorders.
Pirttilä T; Antonen J; Syrjälä P; Frey H
Ann N Y Acad Sci; 1987; 496():691-6. PubMed ID: 3496834
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).
Glikmann G; Svehag SE
Methods Enzymol; 1981; 74 Pt C():571-88. PubMed ID: 6798369
[No Abstract] [Full Text] [Related]
18. Detection of oligoclonal IgG bands in unconcentrated CSF in multiple sclerosis and other neurological diseases by isoelectric focusing on ultrathin-layer polyacrylamide gel immunofixation and silver staining.
Trbojević-Cepe M; Poljaković Z; Franjić J; Bielen I; Vranes Z
Neurologija; 1989; 38(1):11-21. PubMed ID: 2677819
[TBL] [Abstract][Full Text] [Related]
19. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
20. Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria.
Eckman E; Laman JD; Fischer KF; Lopansri B; Martins TB; Hill HR; Kriesel JD
J Mol Med (Berl); 2021 Oct; 99(10):1399-1411. PubMed ID: 34100959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
